Novartis Hires BioVision to Find Clinically Relevant Peptides

Dec 09, 2004

NEW YORK, Dec. 9 (GenomeWeb News) - BioVision will evaluate clinical samples provided by Switzerland-based Novartis Pharmaceuticals as part of a service agreement, BioVision said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Already have an account?
Login Now.

Breaking News

OncoDNA, Everything Genetic Sign Distribution Deal
Luminex Receives FDA Clearance for C. Diff Assay
Top Five Articles on GenomeWeb Last Week: Dogs, Courtagen, Thermo Fisher, and More
Genetic Technologies Facing Nasdaq Delisting
Exosome Diagnostics Completes $30 Million Series C Financing
Researchers Find MRSA Genesis Occurred Years Before Clinical Introduction of Methicillin

The Scan

Helix Launches 'App Store'

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

More CAR-T Therapies Sought

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Telomeres of Spawning Salmon

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

This Week in PLOS

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.

Main menu